Texas Byetta/Januvia/Victoza Lawyer

September 19, 2013 @ 02:37 PM -- by

 

Byetta (exenatide synthetic), a GLP-1 receptor agonist, was approved by the FDA on April 28, 2005 for use by adults with Type 2 Diabetes. If you are a type-2 diabetic who got pancreatic cancer, thyroid cancer or pancreatitis after taking Byetta, Januvia, Victoza or other medications belonging to a class of drugs known as incretin mimetics, you should contact us for a free evaluation as to whether you have a potential lawsuit.